Evidence map›Paper›PMID 28879157›Full record

ArticleAfrican journal of laboratory medicine2017

Evaluation of the SD Bioline TB Ag MPT64 test for identification of

Patrick Orikiriza, Dan Nyehangane, Daniel Atwine, John J Kisakye, Kennedy Kassaza, Juliet-Mwanga Amumpaire, Yap Boum

Open access · diamondAbstract read
In one paragraph

Article in African journal of laboratory medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. TheFrontiers in medicine · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review and Updates on the Diagnosis of Tuberculosis.Journal of clinical medicine · 2022
    Review
  8. Article
  9. Observational
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Patrick OrikirizaEpicentre Mbarara Research Centre, Mbarara, Uganda.
Dan NyehanganeEpicentre Mbarara Research Centre, Mbarara, Uganda.
Daniel AtwineEpicentre Mbarara Research Centre, Mbarara, Uganda.
John J KisakyeDepartment of Biological Sciences, College of Natural Sciences, Makerere University, Kampala, Uganda.
Kennedy KassazaEpicentre Mbarara Research Centre, Mbarara, Uganda.
Juliet-Mwanga AmumpaireEpicentre Mbarara Research Centre, Mbarara, Uganda.
Yap BoumEpicentre Mbarara Research Centre, Mbarara, Uganda.
Epicentre Uganda · UGMakerere University · UG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo confirm presence of

objectivesThe aim of this study was to determine the sensitivity, specificity and turnaround time of the SD MPT64 assay for identification of

methodsA convenience sample of 690 patients, with tuberculosis symptoms, was enrolled at Epicentre Mbarara Research Centre between April 2010 and June 2011. The samples were decontaminated using NALC-NaOH and re-suspended sediments inoculated in Mycobacterium Growth Indicator Tubes (MGIT) media, then incubated at 37 °C for a maximum of eight weeks. A random sample of 50 known negative cultures and 50 non-tuberculous mycobacteria isolates were tested for specificity, while sensitivity was based on AFB positivity. The time required from positive culture to reporting of results was also assessed with PNB used as the gold standard.

resultsOf the 138 cultures that were AFB-positive, the sensitivity of the SD MPT64 assay was 100.0% [95% CI: 97.3 - 100] and specificity was 100.0% (95% CI, 96.4 - 100). The median time from a specimen receipt to confirmation of strain was 10 days [IQR: 8-12] with SD MPT64 and 24 days [IQR: 22-26] with PNB.

conclusionThe SD MPT64 assay is comparable to PNB for identification of

Identifiers

PMID28879157
PMCPMC5523908
OpenAlexW2597990152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.